These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31473490)

  • 1. Development of a thin layer chromatography method for plasma correction of [
    Villar M; Valiente M; Toscano M; Galmés M; González C; Ortiz M; Vega F; Oporto M; Bibiloni P; Chinchilla JL; Molina J; Ríos Á; Peña C; Rubí S
    Nucl Med Biol; 2019; 74-75():34-40. PubMed ID: 31473490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full kinetic modeling analysis of [
    Rubí S; Bibiloni P; Villar M; Brell M; Valiente M; Galmés M; Toscano M; Matheu G; Chinchilla JL; Molina J; Luis Valera J; Ríos Á; López M; Peña C
    Neuroimage Clin; 2024; 42():103616. PubMed ID: 38763039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.
    Bansal A; Shuyan W; Hara T; Harris RA; Degrado TR
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1192-203. PubMed ID: 18264706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of [
    Yagi Y; Kimura H; Okuda H; Ono M; Nakamoto Y; Togashi K; Saji H
    Nucl Med Biol; 2019; 74-75():25-31. PubMed ID: 31450072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
    Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R
    J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography.
    Roivainen A; Forsback S; Grönroos T; Lehikoinen P; Kähkönen M; Sutinen E; Minn H
    Eur J Nucl Med; 2000 Jan; 27(1):25-32. PubMed ID: 10654143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography.
    Li F; Hicks JW; Yu L; Desjardin L; Morrison L; Hadway J; Lee TY
    EJNMMI Res; 2020 Nov; 10(1):141. PubMed ID: 33226509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility.
    Gómez-Río M; Testart Dardel N; Santiago Chinchilla A; Rodríguez-Fernández A; Olivares Granados G; Luque Caro R; Zurita Herrera M; Chamorro Santos CE; Lardelli-Claret P; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):886-95. PubMed ID: 25673054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
    Sorger D; Becker GA; Patt M; Schildan A; Grossmann U; Schliebs R; Seese A; Kendziorra K; Kluge M; Brust P; Mukhin AG; Sabri O
    Nucl Med Biol; 2007 Apr; 34(3):331-42. PubMed ID: 17383583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
    Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
    Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convenient and Efficient Method for Quality Control Analysis of 18F-Fluorocholine: For a Small Scale GMP-based Radiopharmaceuticals Laboratory Set-up.
    Hassan H; Abu Bakar S; Halim KN; Idris J; Nordin AJ
    Curr Radiopharm; 2016; 9(2):128-36. PubMed ID: 26013570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Grkovski M; Kohutek ZA; Schöder H; Brennan CW; Tabar VS; Gutin PH; Zhang Z; Young RJ; Beattie BJ; Zanzonico PB; Huse JT; Rosenblum MK; Blasberg RG; Humm JL; Beal K
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1446-1457. PubMed ID: 31865407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT with
    Kwee SA; Wong L; Chan OTM; Kalathil S; Tsai N
    Radiology; 2018 Apr; 287(1):294-302. PubMed ID: 29315063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of
    Huber GF; Hüllner M; Schmid C; Brunner A; Sah B; Vetter D; Kaufmann PA; von Schulthess GK
    Eur Radiol; 2018 Jun; 28(6):2700-2707. PubMed ID: 29372312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.